The MoLEP project generated a rich set of tools and evidence supporting the relevance of the approach. Novartis is currently considering engaging with the Programme National d'Élimination de la Lèpre (PNEL) in Côte d’Ivoire with the aim of exploring the conditions for the implementation of a…

As populations age, more people live with serious illness and need care at the end of life. Health systems are not keeping pace. Services are often fragmented, and much of the care is given by families, friends and communities. Planning rarely accounts for this contribution, which SHAPE calls social…

Countries often rely on several mortality information systems in parallel, including civil registration and vital statistics (CRVS), sample registration systems (SRS), health and demographic surveillance systems (HDSS), censuses, and household surveys. These systems differ in their costs, population…

The Government of Bangladesh has developed the National Strategic Plan (NSP) for Leprosy 2023–2030, aligned with the WHO Global Leprosy Strategy and NTD Roadmap, aiming to achieve: Zero Infection, Zero Disability, Zero Stigma and Discrimination by 2030. Given the upcoming milestones (2025–2026), an…

Madagascar's National TB Control Programme has identified miners as a high-risk group. However, little evidence exists to explain why, how many miners are affected, which types of mining operations carry the greatest risk, or how TB spreads within these communities. This project, led jointly by…

Over the past two decades Djibouti has undergone a dramatic shift in malaria epidemiology. In the mid-2000s transmission was reliably low, and the national control programme launched in 2006 aimed to eliminate malaria by 2020 through rapid diagnosis, treatment and vector control. Around 2010 cases…

The momentum created by the African local pharmaceutical product manufacturing agenda for sustainable equitable healthcare provision makes the continent the frontier for product development due to the population dividend and disease burden. Local manufacturing will have to be heralded by investment…

Swiss TPH is conducting a structured synthesis of the legacy of the Global Partnership for Zero Leprosy (GPZL). The mandate documents GPZL’s key achievements, products and strategic contributions and captures lessons learned from its partnership and implementation experience. It combines a review of…

In Switzerland, potential health risk of per- and polyfluoroalkyl substances (PFAS), cadmium (Cd), lead (Pb) and arsenic (As) are of concern. In the frame of the menuCH-Kids study, comprehensive data on sociodemographic, lifestyle, dietary and environmental factors have been collected with 1,800…

Drug-resistant tuberculosis (DR-TB) is a critical global health challenge, particularly in low- and middle-income countries where access to rapid and comprehensive diagnostic testing is limited. Early detection of resistance to first- and second-line TB drugs is critical; however, current…